Maroon Biotech welcomes contract research and licensing opportunities. Maroon is currently utilizing its expertise in the biophysics of cellular membrane injury to carry out several R&D projects for outside contractors. Maroon’s intellectual property in the area of cellular membrane repair has numerous compositions that are available for licensing, which include compositions that will enhance gene transfection efficacy and reduce reperfusion injury following myocardial infarction or stroke, and would be particularly valuable opportunities for companies pursuing such technology.

Maroon Biotech is a privately held biotechnology company. For more information on investment, contract, and licensing opportunities with Maroon Biotech, please contact us using the information above.